202 related articles for article (PubMed ID: 32245394)
21. Differential Expression of Hypoxia-Related Genes in Primary Brain Tumors and Correlation with Clinicopathologic Data.
Bayat S; Mamivand A; Khoshnevisan A; Maghrouni A; Shabani S; Raouf MT; Yaseri M; Saffar H; Tabrizi M
World Neurosurg; 2021 Oct; 154():e465-e472. PubMed ID: 34303851
[TBL] [Abstract][Full Text] [Related]
22. The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges.
Fountain DM; Smith MJ; O'Leary C; Pathmanaban ON; Roncaroli F; Bobola N; King AT; Evans DG
Oncogene; 2021 Feb; 40(5):875-884. PubMed ID: 33262459
[TBL] [Abstract][Full Text] [Related]
23. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
24. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.
Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M
Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515
[TBL] [Abstract][Full Text] [Related]
25. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M
Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719
[TBL] [Abstract][Full Text] [Related]
26. Alterations of hypoxia-induced factor signaling pathway due to mammalian target of rapamycin (mTOR) suppression in ovarian clear cell adenocarcinoma: in vivo and in vitro explorations for clinical trial.
Hirasawa T; Miyazawa M; Yasuda M; Shida M; Ikeda M; Kajiwara H; Matsui N; Fujita M; Muramatsu T; Mikami M
Int J Gynecol Cancer; 2013 Sep; 23(7):1210-8. PubMed ID: 23899586
[TBL] [Abstract][Full Text] [Related]
27. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.
Yuzawa S; Nishihara H; Yamaguchi S; Mohri H; Wang L; Kimura T; Tsuda M; Tanino M; Kobayashi H; Terasaka S; Houkin K; Sato N; Tanaka S
Mod Pathol; 2016 Jul; 29(7):708-16. PubMed ID: 27102344
[TBL] [Abstract][Full Text] [Related]
28. Expression of hypoxia inducible factor-1alpha in tumors of patients with glioblastoma multiforme and transitional meningioma.
Kaynar MY; Sanus GZ; Hnimoglu H; Kacira T; Kemerdere R; Atukeren P; Gumustas K; Canbaz B; Tanriverdi T
J Clin Neurosci; 2008 Sep; 15(9):1036-42. PubMed ID: 18621534
[TBL] [Abstract][Full Text] [Related]
29. Clinical potential of meningioma genomic insights: a practical review for neurosurgeons.
Karsy M; Azab MA; Abou-Al-Shaar H; Guan J; Eli I; Jensen RL; Ormond DR
Neurosurg Focus; 2018 Jun; 44(6):E10. PubMed ID: 29852774
[TBL] [Abstract][Full Text] [Related]
30. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
31. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
32. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Clark VE; Harmancı AS; Bai H; Youngblood MW; Lee TI; Baranoski JF; Ercan-Sencicek AG; Abraham BJ; Weintraub AS; Hnisz D; Simon M; Krischek B; Erson-Omay EZ; Henegariu O; Carrión-Grant G; Mishra-Gorur K; Durán D; Goldmann JE; Schramm J; Goldbrunner R; Piepmeier JM; Vortmeyer AO; Günel JM; Bilgüvar K; Yasuno K; Young RA; Günel M
Nat Genet; 2016 Oct; 48(10):1253-9. PubMed ID: 27548314
[TBL] [Abstract][Full Text] [Related]
33. AKT1
John P; Waldt N; Liebich J; Kesseler C; Schnabel S; Angenstein F; Sandalcioglu IE; Scherlach C; Sahm F; Kirches E; Mawrin C
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12780. PubMed ID: 34837233
[TBL] [Abstract][Full Text] [Related]
34. EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.
Angus SP; Oblinger JL; Stuhlmiller TJ; DeSouza PA; Beauchamp RL; Witt L; Chen X; Jordan JT; Gilbert TSK; Stemmer-Rachamimov A; Gusella JF; Plotkin SR; Haggarty SJ; Chang LS; Johnson GL; Ramesh V;
Neuro Oncol; 2018 Aug; 20(9):1185-1196. PubMed ID: 29982664
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha.
Mori A; Moser C; Lang SA; Hackl C; Gottfried E; Kreutz M; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Res; 2009 Aug; 7(8):1390-8. PubMed ID: 19671674
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth.
Nakazawa MS; Eisinger-Mathason TS; Sadri N; Ochocki JD; Gade TP; Amin RK; Simon MC
Nat Commun; 2016 Feb; 7():10539. PubMed ID: 26837714
[TBL] [Abstract][Full Text] [Related]
37. The p75 neurotrophin receptor enhances HIF-dependent signaling in glioma.
Tong B; Pantazopoulou V; Johansson E; Pietras A
Exp Cell Res; 2018 Oct; 371(1):122-129. PubMed ID: 30092219
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.
Catrina SB; Botusan IR; Rantanen A; Catrina AI; Pyakurel P; Savu O; Axelson M; Biberfeld P; Poellinger L; Brismar K
Clin Cancer Res; 2006 Aug; 12(15):4506-14. PubMed ID: 16899596
[TBL] [Abstract][Full Text] [Related]
39. Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
Harmancı AS; Youngblood MW; Clark VE; Coşkun S; Henegariu O; Duran D; Erson-Omay EZ; Kaulen LD; Lee TI; Abraham BJ; Simon M; Krischek B; Timmer M; Goldbrunner R; Omay SB; Baranoski J; Baran B; Carrión-Grant G; Bai H; Mishra-Gorur K; Schramm J; Moliterno J; Vortmeyer AO; Bilgüvar K; Yasuno K; Young RA; Günel M
Nat Commun; 2017 Feb; 8():14433. PubMed ID: 28195122
[TBL] [Abstract][Full Text] [Related]
40. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
